SNGX Soligenix, Inc.
Healthcare$0.51+31.50%ClosedMarket Cap: $5.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.28
P/S
0.00
EV/EBITDA
0.14
DCF Value
$1.26
FCF Yield
-268.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-246.0%
ROA
-158.2%
ROIC
-327.0%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-2.9M | $-2.8M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-3.5M | $-2.9M | $— | — |
| FY null | $0.00 | NaN% | $-11.8M | $-11.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.6M | $-2.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.8M | $-2.7M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.3M | $-3.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-3.7M | $-3.0M | $— | — |
| FY null | $0.00 | -Infinity% | $-9.4M | $-8.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-1.9M | $-1.7M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-1.7M | $-1.6M | $— | — |
| Q1 null | $117.0K | 0.0% | $-2.1M | $-1.9M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-2.1M | $-1.8M | $-2.80 | — |